Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure

International Journal of Cardiology

Volumn 140, Issue 1, 2010, Pages 48-54

  Kurita, Tairo ^a   Onishi, Katsuya ^a   Dohi, Kaoru ^a   Takamura, Takeshi ^a   Fujimoto, Naoki ^a   Tanigawa, Takashi ^a   Imanaka Yoshida, Kyoko ^a   Wada, Hideo ^a   Nobori, Tsutomu ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ACE inhibitor; Conductance catheter; Dyssynchrony; Heart failure

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOG; HEART FAILURE; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART STROKE VOLUME; HEART VENTRICLE PACING; HISTOPATHOLOGY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; QRS COMPLEX; SYSTEMIC VASCULAR RESISTANCE;

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; COMORBIDITY; DISEASE PROGRESSION; DOGS; HEART FAILURE; HEMODYNAMICS; MALE; NOREPINEPHRINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77949489751     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.047     Document Type: Article

References (31)

1. Bleeker G.B., Schalij M.J., Molhoek S.G., et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 15 (2004) 544-549
2. Grines C.L., Bashore T.M., Boudoulas H., Olson S., Shafer P., and Wooley C.F. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation 79 (1989) 845-853
3. Iuliano S., Fisher S.G., Karasik P.E., Fletcher R.D., and Singh S.N. Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure. Am Heart J 143 (2002) 1085-1091
4. Bleeker G.B., Schalij M.J., Molhoek S.G., et al. Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex. Am J Cardiol 95 (2005) 140-142
5. Dohi K., Suffoletto M., Murali S., Bazaz R., and Gorcsan J. Benefit of cardiac resynchronization therapy to a patient with a narrow QRS complex and ventricular dyssynchrony identified by tissue synchronization imaging. Eur J Echocardiogr 6 (2005) 455-460
6. Steendijk P., Tulner S.A., Schreuder J.J., et al. Quantification of left ventricular mechanical dyssynchrony by conductance catheter in heart failure patients. Am J Physiol 286 (2004) H723-H730
7. Yu C.M., Chan Y.S., Zhang Q., et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 48 (2006) 2251-2257
8. Kurita T., Onishi K., Dohi K., et al. Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure and normal QRS duration. Eur J Heart Fail 9 (2007) 637-643
9. Lafitte S., Bordachar P., Lafitte M., et al. Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol 47 (2006) 2253-2259
10. Miura T., Bhargava V., Guth B.D., et al. Increased afterload intensifies asynchronous wall motion and impairs ventricular relaxation. J Appl Physiol 75 (1993) 389-396
11. White J.A., Yee R., Yuan X., et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 48 (2006) 1953-1960
12. Funabiki K., Onishi K., Dohi K., et al. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure. Am J Physiol Heart Circ Physiol 287 (2004) H2487-H2492
13. Chevalier B, Heudes D, Heymes C, Basset A, Dakhli T, Bansard Y, Jouquey S, Hamon G, Bruneval P, Swynghedauw B, Carre F. Trandolapril Decreases Prevalence of Ventricular Ectopic Activity in Middle-Aged SHR Circulation 1995;92:1947-1953.
14. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
15. Bleeker G.B., Bax J.J., Steendijk P., Schalij M.J., and van der Wall E.E. Left ventricular dyssynchrony in patients with heart failure: pathophysiology, diagnosis and treatment. Nat Clin Pract Cardiovasc Med 3 (2006) 213-219
16. Dohi K., Onishi K., Kitamura T., et al. Functional role of endogenous endothelin-1 in congestive heart failure treated with angiotensin II receptor antagonist. Jpn J Physiol 51 (2001) 445-453
17. Koji T., Onishi K., Dohi K., et al. Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism. J Cardiovasc Pharmacol 41 (2003) 632-639
18. Little W.C., Cheng C.P., Mumma M., Igarashi Y., Vinten-Johansen J., and Johnston W.E. Comparison of measures of left ventricular contractile performance from pressure-volume loops in conscious dogs. Circulation 80 (1989) 378-1387
19. Onishi K., Ohno M., Little W.C., and Cheng C.P. Endogenous endothelin-1 depresses left ventricular systolic and diastolic performance in congestive heart failure. J Pharmacol Exp Ther 288 (1999) 1214-1222
20. Van der Velde E.T., van Dijk A.D., Steendijk P., et al. Left ventricular segmental volume by conductance catheter and Cine-CT. Eur Heart J 13 (1992) 15-21
21. Fujii M., Wada A., Tsutamoto T., Ohnishi M., Isono T., and Kinoshita M. Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension 39 (2002) 952-957
22. Barlucchi L., Leri A., Dostal D.E., et al. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ Res 88 (2001) 298-304
23. Wada A., Tsutamoto T., Maeda Y., Kanamori T., Matsuda Y., and Kinoshita M. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure. Am J Physiol Heart Circ Physiol 270 (1996) H1819-H1824
24. Aoyagi T., Pouleur H., Van Eyll C., Rousseau M.F., and Mirsky I. Wall motion asynchrony is a major determinant of impaired left ventricular filling in patients with healed myocardial infarction. Am J Cardiol 72 (1993) 268-272
25. Hayashida W., Kumada T., Kohno F., et al. Left ventricular relaxation in dilated cardiomyopathy: relation to loading conditions and regional nonuniformity. J Am Coll Cardiol 20 (1992) 1082-1091
26. Schreuder J.J., van der Veen F.H., van der Velde E.T., et al. Left ventricular pressure-volume relationships before and after cardiomyoplasty in patients with heart failure. Circulation 96 (1997) 2978-2986
27. Takemoto Y., Hozumi T., Sugioka K., et al. Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex. J Am Coll Cardiol 49 (2007) 778-783
28. Herpel E., Pritsch M., Koch A., Dengler T.J., Schirmacher P., and Schnabel P.A. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology 48 (2006) 736-747
29. Kass D.A. An epidemic of dyssynchrony: But what does it mean?. J Am Coll Cardiol 51 (2008) 12-17
30. Wang J., Kurrelmeyer K.M., Torre-Amione G., and Nagueh S.F. J Am Coll Cardiol 49 (2007) 88-96
31. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150